Baricitinib for Respiratory Injury in Patients With Intracerebral Hemorrhage

Key facts

Sponsor

De-zhi Kang

Principal Investigator

De-zhi Kang, M.D., PA-C

First Affiliated Hospital of Fujian Medical University

Intervention

Baritinib(drug)

Enrollment

110 enrolled

Eligibility

18 years · All sexes

Timeline

2025 – 2025

Study locations (6)

• The Southwest Hospital of Army Medical University, Chongqing, Chongqing Municipality, China
• First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
• First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China
• Ganzhou People's Hospital, Ganzhou, Jiangxi, China
• Liaocheng People's Hospital, Liaocheng Brain Hospital, Liaocheng, Shandong, China
• Tianjin Huanhu Hospital, Tianjin, Tianjin Municipality, China

Collaborators

Fujian Medical University · Tianjin Medical University General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06526598
  Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
  Capital Medical University
• RECRUITINGNANCT07380789
  Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine
  Lviv National Medical University
• RECRUITINGPHASE2, PHASE3NCT07342205
  A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
  Shanghai University of Traditional Chinese Medicine
• RECRUITINGPHASE3NCT07208591
  To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
  Staidson (Beijing) Biopharmaceuticals Co., Ltd
• RECRUITINGPHASE2NCT06513949
  Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
  Implicit Bioscience
• RECRUITINGPHASE2NCT06703073
  JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
  PPD Development, LP
• RECRUITINGPHASE1, PHASE2NCT07413978
  A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome
  Changchun Tuohua Pharmaceutical Co., Ltd.
• RECRUITINGNANCT06772025
  A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine
  Bayer

See all trials for Acute lung injury →